352 related articles for article (PubMed ID: 12639726)
1. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
[TBL] [Abstract][Full Text] [Related]
2. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
[TBL] [Abstract][Full Text] [Related]
3. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
[TBL] [Abstract][Full Text] [Related]
4. Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation.
Sharma J; Sanfilipo MP; Benedict RH; Weinstock-Guttman B; Munschauer FE; Bakshi R
AJNR Am J Neuroradiol; 2004; 25(6):985-96. PubMed ID: 15205136
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.
Zivadinov R; Grop A; Sharma J; Bratina A; Tjoa CW; Dwyer M; Zorzon M
J Neuroimaging; 2005 Jan; 15(1):27-36. PubMed ID: 15574571
[TBL] [Abstract][Full Text] [Related]
7. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
Rudick RA; Fisher E; Lee JC; Duda JT; Simon J
Mult Scler; 2000 Dec; 6(6):365-72. PubMed ID: 11212130
[TBL] [Abstract][Full Text] [Related]
8. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
9. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.
Bakshi R; Neema M; Healy BC; Liptak Z; Betensky RA; Buckle GJ; Gauthier SA; Stankiewicz J; Meier D; Egorova S; Arora A; Guss ZD; Glanz B; Khoury SJ; Guttmann CR; Weiner HL
Arch Neurol; 2008 Nov; 65(11):1449-53. PubMed ID: 19001162
[TBL] [Abstract][Full Text] [Related]
10. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
[TBL] [Abstract][Full Text] [Related]
11. Frontal parenchymal atrophy measures in multiple sclerosis.
Locatelli L; Zivadinov R; Grop A; Zorzon M
Mult Scler; 2004 Oct; 10(5):562-8. PubMed ID: 15471374
[TBL] [Abstract][Full Text] [Related]
12. Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis.
Hemond CC; Chu R; Tummala S; Tauhid S; Healy BC; Bakshi R
Brain Behav; 2018 Aug; 8(8):e01068. PubMed ID: 30019857
[TBL] [Abstract][Full Text] [Related]
13. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.
Bakshi R; Benedict RH; Bermel RA; Jacobs L
J Neuroimaging; 2001 Apr; 11(2):129-36. PubMed ID: 11296581
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
Zhou F; Shiroishi M; Gong H; Zee CS
J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
16. Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis.
Liptak Z; Berger AM; Sampat MP; Charil A; Felsovalyi O; Healy BC; Hildenbrand P; Khoury SJ; Weiner HL; Bakshi R; Guttmann CR
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1465-70. PubMed ID: 18556361
[TBL] [Abstract][Full Text] [Related]
17. An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Kim G; Tauhid S; Dupuy SL; Tummala S; Khalid F; Healy BC; Bakshi R
J Neurol; 2016 Mar; 263(3):531-8. PubMed ID: 26754005
[TBL] [Abstract][Full Text] [Related]
18. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
Bakshi R; Benedict RH; Bermel RA; Caruthers SD; Puli SR; Tjoa CW; Fabiano AJ; Jacobs L
Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
[TBL] [Abstract][Full Text] [Related]
19. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
[TBL] [Abstract][Full Text] [Related]
20. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
Hardmeier M; Wagenpfeil S; Freitag P; Fisher E; Rudick RA; Kooijmans-Coutinho M; Clanet M; Radue EW; Kappos L;
Arch Neurol; 2003 Dec; 60(12):1736-9. PubMed ID: 14676048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
